http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2182581-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-56 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00 |
| filingDate | 1995-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1995-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-2182581-A1 |
| titleOfInvention | Enantiomerically pure(-)-liarozole |
| abstract | This invention relates to the novel enantiomerically pure laevorotatory isomer of liarozole of formula (I) and the pharmaceutically acceptable acid addition salt forms thereof. These compounds are particularly useful in treating disorders which are characterized by an increased proliferation and or abnormal differentiation of normal, preneoplastic or neoplastic epithelial cells. The compounds of formula (I) are particularly useful in the field of oncology. Also disclosed are compositions containing said novel compounds, methods of preparing said novel compounds as well as methods of using the mentioned compounds to treat the mentioned disorders. |
| priorityDate | 1994-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 32.